Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Echo IQASX:EIQ +11.34%15 Days Sales Outstanding is 10,493.75 as of Jun. 2026, which is 1608% above its 10-year median of 614.33. GuruFocus rates ASX:EIQ with a GF Score™ of 15/100. The stock has 3 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Echo IQ ranks worse than 98.34% on this metric.
Echo IQ's average Accounts Receivable for the
six
months ended in Jun. 2026 was A$0.06 Mil. Echo IQ's Revenue for the
six
months ended in Jun. 2026 was A$0.00 Mil.
Hence, Echo IQ's Days Sales Outstanding for the
six
months ended in Jun. 2026 was 10,493.75.
The historical rank and industry rank for Echo IQ's Days Sales Outstanding or its related term are showing as below:
ASX:EIQ'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 91.8 Med: 614.33 Max: 10061.83
Current: 436.41
During the past 13 years, Echo IQ's highest Days Sales Outstanding was 10061.83. The lowest was 91.80. And the median was 614.33.
ASX:EIQ's Days Sales Outstanding is ranked worse than 98.34% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 45.78
vs ASX:EIQ: 436.41
Echo IQ's Days Sales Outstanding
increased
from Jun. 2025 (0.00) to Jun. 2026 (10,493.75).
Echo IQ (ASX:EIQ) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Echo IQ Days Sales Outstanding Related Terms
Echo IQ Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Echo IQ's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:EIQ vs VEEV, BTSG, TEM: Days Sales Outstanding Comparison
For the Health Information Services subindustry, Echo IQ's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Echo IQ Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Echo IQ's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Echo IQ's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 10,493.75 mean?
Echo IQ (ASX:EIQ) has a Days Sales Outstanding of 10,493.75 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Echo IQ and its competitors. This is 1608% above median its historical median of 614.33. Over the past decade, Echo IQ's Days Sales Outstanding has ranged from 91.80 to 10,061.83. According to the industry distribution chart, Echo IQ ranks #653 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 98.3%.
Is Echo IQ's Days Sales Outstanding too high?
Echo IQ's current Days Sales Outstanding of 10,493.75 is 1608% above median its 10-year median of 614.33. Over the past 10 years, this metric has ranged from a low of 91.80 to a high of 10,061.83. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.78. Echo IQ's value of 10,493.75 is 22822.1% above this industry median. Based on the distribution chart, Echo IQ ranks #653 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Echo IQ has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Echo IQ's Days Sales Outstanding compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Echo IQ ranks #653 out of 664 companies for Days Sales Outstanding. This places Echo IQ in the lower half of its industry. The industry median Days Sales Outstanding is 45.78. Echo IQ's value of 10,493.75 is 22822.1% above this benchmark. Historically, Echo IQ's own Days Sales Outstanding has ranged from 91.80 to 10,061.83 over the past decade. While the company's 10-year median is 614.33 vs. the industry median of 45.78, Echo IQ has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.78, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Echo IQ's current Days Sales Outstanding of 10,493.75 is 22822.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Echo IQ and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Echo IQ's current Days Sales Outstanding is 10,493.75, which is 1608% above median its own 10-year median of 614.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Echo IQ stock overvalued right now?
Echo IQ (ASX:EIQ) has a current Days Sales Outstanding of 10,493.75. The current Days Sales Outstanding is 10,493.75, which is 1608% above median its 10-year median of 614.33 and 22822.1% above the Healthcare Providers & Services industry median of 45.78. Echo IQ's overall GF Score™ is 15/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Echo IQ (ASX:EIQ), the current Days Sales Outstanding is 10,493.75 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care.
15GF Score
Get the complete analysis for ASX:EIQ
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EIQ has been successfully added to your 
